1. Home
  2. FRHC vs ABVX Comparison

FRHC vs ABVX Comparison

Compare FRHC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freedom Holding Corp.

FRHC

Freedom Holding Corp.

HOLD

Current Price

$133.21

Market Cap

8.7B

Sector

Finance

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$113.96

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRHC
ABVX
Founded
N/A
2013
Country
United States
France
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FRHC
ABVX
Price
$133.21
$113.96
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$112.83
AVG Volume (30 Days)
90.9K
1.4M
Earning Date
11-07-2025
08-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,563,510,000.00
$7,073,400.00
Revenue This Year
N/A
$6.80
Revenue Next Year
N/A
N/A
P/E Ratio
$1,722.97
N/A
Revenue Growth
16.04
N/A
52 Week Low
$111.85
$4.77
52 Week High
$194.01
$130.25

Technical Indicators

Market Signals
Indicator
FRHC
ABVX
Relative Strength Index (RSI) 38.02 54.48
Support Level $131.00 $107.06
Resistance Level $138.27 $130.25
Average True Range (ATR) 4.52 6.32
MACD 0.91 -1.65
Stochastic Oscillator 20.28 32.70

Price Performance

Historical Comparison
FRHC
ABVX

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: